Medicines Development & Delivery

BiologIC Technologies is developing the first world's biocomputer leveraging foundational IP and the latest 3D printing technologies.
Visit company site
Richard Vellacott
CEO

Using an innovative platform technology called PODS, Cell Guidance Systems can stabilize and sustainably release proteins for a variety of applications.
Visit company site
Michael Jones
Founder & CEO

A specialist biotech company focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices.
Visit company site
Dr Alvaro Goyanes
CEO

LightOx has developed a new light activated chemotherapy drug for the treatment and prevention of early-stage oral cancers and is current taking this drug into clinical trials.
Visit company site
Dr Sam Whitehouse
CEO

Medherant develops patches for transdermal drug delivery using a novel, proprietary, solvent-free adhesive technology.
Visit company site
Nigel Davis
Chief Business Officer

Offering a flexible manufacturing platform that closes, automates and standardizes cell and gene therapy manufacturing.
Visit company site
Jason Foster
CEO

A regenerative medicine company, pioneering synthetic nanoclays as a delivery platform for safe and precise tissue regeneration.
Visit company site
Agnieszka Janeczek
CEO

Supporting RNA delivery through its proprietary Bio-Courier® technology with the hybridization of organic materials with inorganic bioabsorbable silicon.
Visit company site
Suzanne Saffie-Siebert
Founder & CEO

A biotechnology company dedicated to delivering effective and safe nucleic acid therapies to save lives and improve health.
Visit company site
Shadi Farhangrazi
CEO
Category Winners
See our 2023 Category Winners
Meet our 6 Category Winners selected for being market leading
UK Innovators in life sciences.